BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32928636)

  • 21. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
    J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.
    Willeumier JJ; Rueten-Budde AJ; Jeys LM; Laitinen M; Pollock R; Aston W; Dijkstra PD; Ferguson PC; Griffin AM; Wunder JS; Fiocco M; van de Sande MA
    BMJ Open; 2017 Feb; 7(2):e012930. PubMed ID: 28196946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limbs and trunk soft tissue sarcoma systematic local and remote monitoring by MRI and thoraco-abdomino-pelvic scanner: A single-centre retrospective study.
    De Angelis F; Guy F; Bertaut A; Méjean N; Varbedian O; Hervieu A; Truc G; Thibouw D; Barra CC; Fraisse J; Burnier P; Isambert N; Causeret S
    Eur J Surg Oncol; 2019 Jul; 45(7):1274-1280. PubMed ID: 30765271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Yada Y; Hagi T; Sudo A
    PLoS One; 2017; 12(7):e0181787. PubMed ID: 28727824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI surveillance for local recurrence in extremity soft tissue sarcoma.
    Park JW; Yoo HJ; Kim HS; Choi JY; Cho HS; Hong SH; Han I
    Eur J Surg Oncol; 2019 Feb; 45(2):268-274. PubMed ID: 30352764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Local Recurrence in Patients With Myxofibrosarcoma.
    Odei B; Rwigema JC; Eilber FR; Eilber FC; Selch M; Singh A; Chmielowski B; Nelson SD; Wang PC; Steinberg M; Kamrava M
    Am J Clin Oncol; 2018 Sep; 41(9):827-831. PubMed ID: 28640064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.
    Iwata S; Yonemoto T; Araki A; Ikebe D; Kamoda H; Hagiwara Y; Ishii T
    J Surg Oncol; 2014 Nov; 110(6):707-11. PubMed ID: 24975462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases.
    Nascimento AF; Bertoni F; Fletcher CD
    Am J Surg Pathol; 2007 Jan; 31(1):99-105. PubMed ID: 17197925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of the tail-like pattern in soft-tissue sarcomas on magnetic resonance imaging.
    Morii T; Tajima T; Honya K; Aoyagi T; Ichimura S
    J Orthop Sci; 2018 Nov; 23(6):1032-1037. PubMed ID: 30017714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized Myxofibrosarcoma: A Retrospective Analysis of Primary Therapy and Prognostic Factors in 134 Patients in a Single Institution.
    Pogkas A; Reichardt P; Tunn PU; Niethard M; Werner M; Ghani S
    Oncologist; 2024 Apr; 29(4):e544-e552. PubMed ID: 38141181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is an adequate margin for infiltrative soft-tissue sarcomas?
    Fujiwara T; Stevenson J; Parry M; Tsuda Y; Tsoi K; Jeys L
    Eur J Surg Oncol; 2020 Feb; 46(2):277-281. PubMed ID: 31627932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant.
    Scoccianti G; Ranucci V; Frenos F; Greto D; Beltrami G; Capanna R; Franchi A
    J Surg Oncol; 2016 Jul; 114(1):50-5. PubMed ID: 27076198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
    Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
    Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up.
    Lemeur M; Mattei JC; Souteyrand P; Chagnaud C; Curvale G; Rochwerger A
    Orthop Traumatol Surg Res; 2015 Feb; 101(1):103-7. PubMed ID: 25583234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.
    Dürr HR; Rauh J; Baur-Melnyk A; Knösel T; Lindner L; Roeder F; Jansson V; Klein A
    BMC Cancer; 2018 Mar; 18(1):304. PubMed ID: 29558901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of re-staging chest CT at first local recurrence of extremity and trunk soft tissue sarcoma.
    Baig MS; Habib W; Attard V; Sharif B; Lindsay D; Upadhyay B; Saifuddin A
    Eur Radiol; 2021 Apr; 31(4):2377-2383. PubMed ID: 33037910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA.
    Zumárraga JP; Batista FAR; Baptista AM; Caiero MT; Martino LPR; de Camargo OP
    Acta Ortop Bras; 2018; 26(5):320-324. PubMed ID: 30464713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation.
    Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C
    Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Lee AY; Agaram NP; Qin LX; Kuk D; Curtin C; Brennan MF; Singer S
    Ann Surg Oncol; 2016 Mar; 23(3):818-25. PubMed ID: 26759307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.